Where does Novozymes, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Novozymes, Inc. ranks #1,932 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Novozymes, Inc. hold?

Novozymes, Inc. holds 208 US utility patents granted between 2015 and 2025, spanning 24 technology areas.

What is Novozymes, Inc.'s Innovation Score?

Novozymes, Inc. has an Innovation Score of 51.5 out of 100 (top 11% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Novozymes, Inc.'s patent grant rate increasing or decreasing?

Novozymes, Inc.'s recent grant velocity is -84% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Novozymes, Inc.'s patents?

Novozymes, Inc.'s patents average 26.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Novozymes, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Novozymes, Inc.

Q: What technology areas does Novozymes, Inc. focus on?

Novozymes, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 199 patents, ranking #34 of 4,144 assignees active in that subclass. Grants appear in 24 CPC subclasses total.

USPTO PatentsView assignee record - 208 granted patents across 24 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Novozymes ranks #1,932 of 49,997 tracked US assignees by granted-patent volume, with 208 patents across 24 technology areas.

#1,932
of 49,997 US assignees by volume: Top 11%
by Innovation Score (51.5/100): 26.0
avg claims per patent: -84%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1932 · US Corporation #1,932 · 208 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MID 208 grants
TOP-DECILE #1,932/49,997
PHOTO-FINISH Becton Dickinson…
CPC-FOCUS C12N · 24 areas
INNOV-PAR 51.5/100
CLAIMS-DENSE 26.0 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -84% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Becton Dickinson France (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Novozymes’s 51.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 18.5 pts (36%) Velocity 0.7 pts (1%) Breadth 17.3 pts (34%) Claim depth 15.0 pts (29%)

Qualcomm Incorporated · highest

85
GN Audio A/S · near

51
Novozymes · this assignee

51
Precision Combustion · near

51
Shaper Tools · near

51
Sumitomo Electric… · near

51
3D Lighting… · lowest

7

What this shows Novozymes's Innovation Score is 51.5/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Novozymes?

Each dot is one of Novozymes’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Novozymes’s own 26.0 claims/patent is ABOVE the 13.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Novozymes vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Novozymes's grants concentrate

Novozymes, Inc. is a focused PatentsView assignee: 24 CPC subclasses with 95.7% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2017 (41 grants) versus a trough of 1 in 2023. By volume, Novozymes sits between Becton Dickinson France and Fujitsu General Limited.

Novozymes's three-year grant acceleration

From 2019–2021 to 2022–2024, Novozymes, Inc. moved from 49 to 5 grants (0.10x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #3,173. See the growth leaderboard.

Becton Dickinson…

208
Fiskars Finland O…

208
JT International

208
Medtronic Ardian…

208
Rain Bird

208
Zephyros

208
Novozymes ◀

208
Cole Haan

207
Fujitsu General

207

What this shows Novozymes holds 208 patents at rank #1,932, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Novozymes

By rank, the assignees closest to #1,932 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Novozymes's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Novozymes, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Novozymes ranks #34 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (51 here).

GN Audio A/S 51 Sumitomo Electric Device Innovations, Inc. 51 Precision Combustion, Inc. 51 Shaper Tools, Inc. 51

Similar claim depth

Nearest assignees by average claims per patent (26.0 here).

Alnylam Pharmaceuticals, Inc. 26.0 avg Omya International AG 26.0 avg Incyte Corporation 26.1 avg CompoSecure, LLC 26.0 avg

Novozymes's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 11% higher than 89% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Novozymes, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	36	17.3%
2016	38	18.3%
2017	41	19.7%
2018	36	17.3%
2019	25	12.0%
2020	13	6.3%
2021	11	5.3%
2022	3	1.4%
2023	1	0.5%
2024	1	0.5%
2025partial year	3	1.4%

Which technologies does Novozymes, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 199

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 178

C12Y - Enzymes 158

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 118

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 62

C07K - Peptides 56

C11D - Detergent COMPOSITIONS; USE OF Single Substances AS DETERGENTS; Soap OR SOAP-MAKING; Resin SOAPS; Recovery OF Glycerol 18

D21C - Production OF Cellulose BY Removing Non-cellulose Substances From Cellulose-containing MATERIALS; Regeneration OF Pulping LIQUORS; Apparatus Therefor 10

H10K - Organic Electric Solid-state Devices 7

C07D - Heterocyclic Compounds 7

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 6

C13K - Saccharides Obtained From Natural Sources OR BY Hydrolysis OF Naturally Occurring Disaccharides, Oligosaccharides OR Polysaccharides 6

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 6

D21H - Pulp COMPOSITIONS; Preparation Thereof NOT Covered BY Subclasses D21c OR D21D; Impregnating OR Coating OF PAPER; Treatment OF Finished Paper NOT Covered BY Class B31 OR Subclass D21G; Paper NOT Otherwise Provided FOR 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

Top 15 of 24 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Novozymes, Inc.'s patent record in context - here's where to go next.

Novozymes, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 95.7% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #1,932 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Novozymes, Inc. against Becton Dickinson France, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 51.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.